CRCA vs. USD
CRCA (ProShares Ultra CRCL) and USD (ProShares Ultra Semiconductors) are both Leveraged Equities funds from ProShares. CRCA is actively managed, while USD is passively managed. At a 0.31 correlation, their price movements are largely independent. Both charge a 0.95% expense ratio.
Performance
CRCA vs. USD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -68.22% return, which is significantly lower than USD's 70.32% return.
CRCA
- 1D
- -9.58%
- 1M
- -40.68%
- 6M
- -70.42%
- YTD
- -68.22%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
USD
- 1D
- -8.00%
- 1M
- -8.85%
- 6M
- 60.45%
- YTD
- 70.32%
- 1Y
- 127.92%
- 3Y*
- 99.92%
- 5Y*
- 59.89%
- 10Y*
- 57.21%
CRCA vs. USD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -68.22% | -84.67% |
USD ProShares Ultra Semiconductors | 70.32% | 21.69% |
Correlation
The correlation between CRCA and USD is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. USD — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
USD
CRCA vs. USD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and ProShares Ultra Semiconductors (USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | USD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.29 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 4.05 | — |
| Martin ratioReturn relative to average drawdown | — | 10.59 | — |
Loading charts...
Drawdowns
CRCA vs. USD - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.18%, which is greater than USD's maximum drawdown of -88.63%. Use the drawdown chart below to compare losses from any high point for CRCA and USD.
Loading charts...
Drawdown Indicators
| CRCA | USD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.18% | -88.63% | -6.55% |
Max Drawdown (1Y)Largest decline over 1 year | — | -31.80% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -64.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -77.85% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -77.85% | — |
Current DrawdownCurrent decline from peak | -95.13% | -21.31% | -73.82% |
Average DrawdownAverage peak-to-trough decline | -72.99% | -32.25% | -40.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 12.13% | — |
Volatility
CRCA vs. USD - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | USD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 32.41% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 57.60% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 195.27% | 70.64% | +124.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 195.27% | 78.22% | +117.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 195.27% | 70.05% | +125.22% |
CRCA vs. USD - Expense Ratio Comparison
Both CRCA and USD have an expense ratio of 0.95%.
Dividends
CRCA vs. USD - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 6.93%, more than USD's 0.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 6.93% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USD ProShares Ultra Semiconductors | 0.34% | 0.39% | 0.10% | 0.05% | 0.30% | 0.00% | 0.14% | 0.72% | 0.93% | 0.32% | 0.46% | 0.39% |
Frequently Asked Questions
CRCA and USD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.95% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA and USD have the same expense ratio: 0.95% per year.
CRCA has the higher dividend yield at 6.93%, compared with 0.34% for USD.
Find the right allocation for CRCA and USD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer